INVESTIGATION PRODUCT COMPLAINT (FORM M)
Division of Allergy, Immunology and Transplantation (DAIT) National Institute of Allergy and Infectious
Diseases (NIAID) National Institutes of Health (NIH)
INSTRUCTIONS ON HOW TO COMPLETE Form M
Pharmacist of Record (PoR)/ Study Personnel
1. Type or handwrite legibly. File a copy of this form in the study Pharmacy Binder.
2. Provide a detailed complaint description in Section C of this form.
3. If an associated Adverse Event (AE) or Serious Adverse Event (SAE) occurs, in addition to completing
this form, complete and submit an AE/SAE electronic case report form (eCRF) in Electronic Data
Capture (EDC). The PoR will communicate with the study coordinator & Principal Investigator (PI) to
complete the eCRF.
4. If an associated Protocol Deviation (PD) related to the product occurs (e.g. when a defective/
damaged/malfunctioned product/ Device has been prepared and/or administered to/ for a participant
OR participant did not receive IP on schedule as per protocol due to any of the stated reasons), in
addition to completing this form, complete and submit PD eCRF in EDC. The PoR will communicate
with the study coordinator to complete the eCRF.
5. Include Participant ID # when a defective/ damaged/ malfunctioned Product/ Device has been
prepared and/or administered to/ for a participant.
6. This form must be filled out and submitted** within 24 hours of event occurrence by email or fax to:
629-1972
AND
or (240) 627-3512.
7. Do not send any affected Product(s) or Device(s) prior to receiving an authorization from DAIT
Pharmaceutical Specialist (PS).
DAIT Pharmaceutical Specialist (PS):
1. Upon receipt of complaint Form M, DAIT PS to assign a product complaint number and notify DAIT
Project Manager (PM), Medical Monitor (MM) and Safety (in a blinded fashion for blinded studies).
Provide safety report # when applicable.
2. DAIT PS to report complaint to DAIT Clinical Product Center (CPC) EMINENT Services Corporation
and Manufacturer (if applicable) within 72 hours of receipt.
3. If products are not purchased, DAIT PS to report the complaint to Manufacturer within 72 hours and
inform DAIT PM, MM, Regulatory and provide report references.
4. For complaints requiring mandatory safety reporting to Health Authorities (HA), DAIT PS to
communicate with DAIT Regulatory, Safety and Clinical team to ensure a MedWatch FDA Form
3500A is filed by the responsible entity.
DAIT Clinical Products Center (CPC):
1. Upon receipt of Form M, DAIT CPC to immediately inform DAIT PS.
2. If products are purchased, DAIT CPC to report the complaint to Manufacturer within 72 hours,
inform DAIT PS and provide report references.
3. If products are not purchased, refer to DAIT PS section here.
** This form may contain information susceptible to unblind the blinded study
staff. Please ensure blinding is maintained during communications.